<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22577" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hartnup Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Mydah S.</given-names>
          </name>
          <aff>Army Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mydah Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22577.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hartnup disease is an autosomal recessive disorder resulting in impaired functioning of transport proteins in the intestines and kidneys. This results in the wasting of neutral amino acids, which manifests as cutaneous and neurologic clinical symptoms. This activity describes the various etiological factors, pathophysiology, and management of patients with Hartnup disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the pathophysiology of Hartnup disease.</p></list-item><list-item><p>Assess&#x000a0;the spectrum of clinical symptoms with which the patient presents in Hartnup disease.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment options available for Hartnup disease.</p></list-item><list-item><p>Communicate&#x000a0;the importance of an interprofessional team approach for managing Hartnup disease most effectively.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22577&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22577">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22577.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Amino acids are building blocks for protein. There are&#x000a0;3 types of amino acids based on the polarity of the side chain. It includes acidic, basic, and neutral amino acids. Hartnup disease is an autosomal recessive inherited nutritional disorder due to decreased absorption of neutral amino acids from the gut and kidney. It has a wide range of clinical spectrum, including neutral aminoaciduria, indicanuria, photosensitive pellagra-like skin rash, cerebellar ataxia, anxiety, depression, and mild intellectual disability.<xref ref-type="bibr" rid="article-22577.r1">[1]</xref>&#x000a0;The clinical symptoms occur intermittently and are influenced by environmental factors, season, stress, and malnutrition.<xref ref-type="bibr" rid="article-22577.r2">[2]</xref> Some patients remain asymptomatic and are diagnosed through routine screening.<xref ref-type="bibr" rid="article-22577.r3">[3]</xref><xref ref-type="bibr" rid="article-22577.r4">[4]</xref></p>
      </sec>
      <sec id="article-22577.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hartnup disease has a genetic etiology. SLC6A19 is a gene located on the short arm of chromosome 5 that encodes transport protein B0AT1 present at the apical cell surface of the small intestine and kidney. Immunohistochemical studies showed maximum expression of B0AT1 in the early proximal convoluted tubules in the kidney and jejunum in the small intestine.<xref ref-type="bibr" rid="article-22577.r5">[5]</xref>&#x000a0;Mutation in the SLC6A19 gene is responsible for Hartnup disease. The mutations noted to cause the disease are missense, splice site, frameshift, and nonsense.<xref ref-type="bibr" rid="article-22577.r5">[5]</xref> The activation and trafficking of B0AT1 to the cell surface occurs via a specific type 1 membrane protein. These are collectrin at the kidneys and angiotensin-converting enzyme 2 at the intestines.<xref ref-type="bibr" rid="article-22577.r6">[6]</xref><xref ref-type="bibr" rid="article-22577.r7">[7]</xref>&#x000a0;They activate it by catabolic reactions and transport B0AT1 to the apical cell surface. The human ACE 2 gene encodes angiotensin-converting enzyme 2, and the CLTRN gene encodes collectrin protein. Both genes are located at the X chromosome band Xp22.2. Mutations in these genes result in sequestration and reduced surface expression of the B0AT1 transporter, which presents with clinical symptoms of Hartnup disease. Hartnup disease has a wide range of clinical symptoms as it can result from a mutation in the transport protein B0AT1 or co-receptors collectrin and ACE2.</p>
      </sec>
      <sec id="article-22577.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of Hartnup disease is 1 in 15,000 live births.<xref ref-type="bibr" rid="article-22577.r1">[1]</xref> Hartnup disease was first described by Baron et al in 1956 in a family in England where&#x000a0;4 siblings were affected.<xref ref-type="bibr" rid="article-22577.r8">[8]</xref>&#x000a0;The condition was first described in a boy in the Hartnup family who presented with photosensitive rash, ataxia, hand tremors, and gait disturbances. On investigation of further family members, his other&#x000a0;3 siblings were also found to have the same syndrome with varying clinical symptoms. Hartnup disease has an early age of onset, with most patients presenting in childhood. It is inherited in an autosomal recessive pattern and has no sexual predilection.</p>
      </sec>
      <sec id="article-22577.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Protein digestion begins in the stomach by the action of pepsinogen. The proteins are then broken down into smaller peptides by the action of various enzymes secreted by the pancreas and enzymes present at the brush border of the small intestine. These enzymes break down proteins into tripeptides, dipeptides, and amino acids. Most amino acids are absorbed in jejunum through a special transport protein located at the apical surface of brush borders. B0AT1 is a sodium-dependent co-transport protein for absorbing neutral amino acids at the apical surface of the small intestine and renal tubular cells. The absorption of neutral amino acids is independent of chloride concentration. The absorbed neutral amino acids are transported via the blood to other organs. In the kidney, it is filtered through the glomerulus, where it is reabsorbed through B0AT1 membrane protein located in proximal tubular cells.<xref ref-type="bibr" rid="article-22577.r5">[5]</xref></p>
        <p>In Hartnup disease, there is a defect in the B0AT1 protein, resulting in excessive excretion of neutral amino acids in urine and feces. A small amount of neutral amino acids is absorbed in the gut directly via paracellular transport and as oligopeptides from proton counter-transport proteins.<xref ref-type="bibr" rid="article-22577.r9">[9]</xref>&#x000a0;Excess tryptophan present in the gut is converted to indolic compounds by the action of colonic bacteria. These indolic compounds are conjugated in the liver and excreted as indican in urine.<xref ref-type="bibr" rid="article-22577.r10">[10]</xref> Tryptophan is a neutral amino acid that is a precursor for niacin. Wasting of tryptophan results in niacin deficiency manifesting as pellagra-like skin eruptions and neurological symptoms.<xref ref-type="bibr" rid="article-22577.r10">[10]</xref>&#x000a0;An excess of leucine in the brain competes with other neutral amino acids, including tryptophan, for binding by transporters in the glial cell membranes. Tryptophan is needed for the production of serotonin.<xref ref-type="bibr" rid="article-22577.r11">[11]</xref></p>
      </sec>
      <sec id="article-22577.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The patients present with intermittent and reversible episodes of cutaneous and neurological clinical symptoms aggravated by sunlight, hot weather, and nutritional deficiency. The skin eruptions that resemble pellagra are erythematous, scaly, and present in sun-exposed areas of skin. There have been reports of improvement of the skin rash with nicotinamide supplementation.<xref ref-type="bibr" rid="article-22577.r4">[4]</xref> Neurological symptoms range from tremors, ataxia, mood disorders, depression, convulsions, and psychosis.<xref ref-type="bibr" rid="article-22577.r10">[10]</xref>&#x000a0;Developmental milestones are normal in children, but below-normal academic performance and short stature have been noted.<xref ref-type="bibr" rid="article-22577.r4">[4]</xref> The clinical symptoms improve with age when protein demand decreases. Patients may remain asymptomatic throughout life if their niacin intake is adequate.</p>
      </sec>
      <sec id="article-22577.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of Hartnup disease is determined by urine analysis, which shows neutral aminoaciduria except for proline. The neutral amino acids (valine, serine, phenylalanine, histidine, glutamine, leucine, asparagine, citrulline, isoleucine, threonine, alanine, tyrosine, tryptophan) undergo analysis by paper chromatography of urine. Indican is also present in the urine and is produced as a by-product of tryptophan degradation by colonic bacteria.</p>
      </sec>
      <sec id="article-22577.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The main aim of treatment is to prevent the occurrence of clinical episodes. Hartnup disease is treatable by a high-protein diet. Patients should have a well-balanced diet, as episodes are more frequent in individuals who are malnourished and have maize as their staple diet. Nicotinamide supplements ameliorate skin eruptions and neurological symptoms in patients with niacin deficiency.<xref ref-type="bibr" rid="article-22577.r12">[12]</xref>&#x000a0;Patients with neurological symptoms require a complete neurological workup. Appropriate psychiatric and neurological treatments may be needed to resolve the neuropsychiatric symptoms.<xref ref-type="bibr" rid="article-22577.r4">[4]</xref></p>
      </sec>
      <sec id="article-22577.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Hartnup disease requires differentiation from other conditions that result in a photosensitive skin rash, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nutritional pellagra</p>
          </list-item>
          <list-item>
            <p>Lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Congenital poikiloderma</p>
          </list-item>
          <list-item>
            <p>Carcinoid syndrome</p>
          </list-item>
          <list-item>
            <p>Seborrheic eczema&#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <p>Nutritional pellagra has normal urine analysis. Lupus has specific antinuclear (ANA), anti-Smith, and anti-double-stranded (anti-ds Ab) antibodies in plasma. Carcinoid syndrome is associated with flushing, diarrhea, and elevated levels of 5-hydroxy indoleacetic acid(5-HIAA) in urine. Seborrheic eczema has yellow crusting on skin lesions and a history of allergies.<xref ref-type="bibr" rid="article-22577.r13">[13]</xref></p>
      </sec>
      <sec id="article-22577.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The severity of symptoms decreases with age.<xref ref-type="bibr" rid="article-22577.r10">[10]</xref> There is a low incidence of recurrence of symptoms with a high protein diet and niacin supplement. The prognosis is good. The patients have a normal life expectancy with low morbidity.<xref ref-type="bibr" rid="article-22577.r14">[14]</xref></p>
      </sec>
      <sec id="article-22577.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications for Hartnup disease include:</p>
        <list list-type="order">
          <list-item>
            <p>Severe neurodegenerative symptoms, including seizures, psychosis, and delirium.<xref ref-type="bibr" rid="article-22577.r15">[15]</xref><xref ref-type="bibr" rid="article-22577.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Skin hyperpigmentation and xerosis at the site of eruptive skin lesions.<xref ref-type="bibr" rid="article-22577.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Developmental retardation and below-average school performance have been reported.<xref ref-type="bibr" rid="article-22577.r18">[18]</xref><xref ref-type="bibr" rid="article-22577.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22577.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should take preventive measures to prevent episodes of Hartnup disease. Preventive measures include avoiding direct sunlight, wearing protective clothing, and applying sunblock outdoors, as hot weather and sunlight exacerbate skin lesions.&#x000a0;Drugs like sulfonamides, nonsteroidal anti-inflammatory medicines, tetracyclines, and oral contraceptives that increase sensitivity to light should also be avoided.</p>
      </sec>
      <sec id="article-22577.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;Hartnup disease include:</p>
        <list list-type="bullet">
          <list-item>
            <p>The clinical course of Hartnup disease is intermittent, with episodes of exacerbating cutaneous and neurological symptoms.</p>
          </list-item>
          <list-item>
            <p>Sunlight, nutritional deficiency, and hot weather are known factors that exaggerate the symptoms, but patients can present clinically even in the absence of any of the exacerbating factors.</p>
          </list-item>
          <list-item>
            <p>The exact causative factor for neurological symptoms remains unestablished. Yet, there is a theory that indolic compounds formed in the gut from the degradation of excess tryptophan by colonic bacteria are responsible for neurological symptoms.<xref ref-type="bibr" rid="article-22577.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Patients presenting with pellagra-like skin eruptions and neurological symptoms like ataxia, tremors, and mood disorders should be initiated with a high oral niacin dose, and urine should be checked for neutral amino acids.</p>
          </list-item>
          <list-item>
            <p>There has been a case report that described a patient on a high tryptophan diet with a normal niacin level presenting with photosensitive skin eruptions and neurological symptoms in the summer.<xref ref-type="bibr" rid="article-22577.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Patients are monitored regularly for long-term to assess the progression of neurological symptoms.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22577.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team involving a primary care physician, nutritionist, and neurologist should manage the patient. Routine newborn screening for Hartnup disease is not standard at present. Patients presenting with skin rash similar to pellagra, tremors, or ataxia at a young age should be evaluated for Hartnup disease as it is easily treatable. Interprofessional collaboration is important to improve patient outcomes in Hartnup disease.</p>
      </sec>
      <sec id="article-22577.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22577&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22577">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/hartnup-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22577">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22577/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22577">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22577.s16">
        <title>References</title>
        <ref id="article-22577.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pillai</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Yubero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shayota</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Oyarz&#x000e1;bal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Azamian</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Arjona</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brandi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Palau</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lalani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Artuch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Cazorla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Loss of CLTRN function produces a neuropsychiatric disorder and a biochemical phenotype that mimics Hartnup disease.</article-title>
            <source>Am J Med Genet A</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>179</volume>
            <issue>12</issue>
            <fpage>2459</fpage>
            <page-range>2459-2468</page-range>
            <pub-id pub-id-type="pmid">31520464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freundlich</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Statter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yatziv</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Familial pellagra-like skin rash with neurological manifestations.</article-title>
            <source>Arch Dis Child</source>
            <year>1981</year>
            <month>Feb</month>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>146</fpage>
            <page-range>146-8</page-range>
            <pub-id pub-id-type="pmid">6451201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seakins</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ersser</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Effects of amino acid loads on a health infant with the biochemical features of Hartnup disease.</article-title>
            <source>Arch Dis Child</source>
            <year>1967</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>226</issue>
            <fpage>682</fpage>
            <page-range>682-8</page-range>
            <pub-id pub-id-type="pmid">6073838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilcken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Natural history of Hartnup disease.</article-title>
            <source>Arch Dis Child</source>
            <year>1977</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-40</page-range>
            <pub-id pub-id-type="pmid">836052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Br&#x000f6;er</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Apical transporters for neutral amino acids: physiology and pathophysiology.</article-title>
            <source>Physiology (Bethesda)</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>23</volume>
            <fpage>95</fpage>
            <page-range>95-103</page-range>
            <pub-id pub-id-type="pmid">18400692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danilczyk</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Sarao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Remy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Benabbas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stange</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pospisilik</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Makrides</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ramadan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Verrey</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Penninger</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Essential role for collectrin in renal amino acid transport.</article-title>
            <source>Nature</source>
            <year>2006</year>
            <month>Dec</month>
            <day>21</day>
            <volume>444</volume>
            <issue>7122</issue>
            <fpage>1088</fpage>
            <page-range>1088-91</page-range>
            <pub-id pub-id-type="pmid">17167413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kowalczuk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Br&#x000f6;er</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tietze</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vanslambrouck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rasko</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Br&#x000f6;er</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A protein complex in the brush-border membrane explains a Hartnup disorder allele.</article-title>
            <source>FASEB J</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>2880</fpage>
            <page-range>2880-7</page-range>
            <pub-id pub-id-type="pmid">18424768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BARON</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>DENT</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>HARRIS</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>HART</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>JEPSON</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features.</article-title>
            <source>Lancet</source>
            <year>1956</year>
            <month>Sep</month>
            <day>01</day>
            <volume>271</volume>
            <issue>6940</issue>
            <fpage>421</fpage>
            <page-range>421-8</page-range>
            <pub-id pub-id-type="pmid">13358233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matthews</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Intestinal absorption of amino acids and peptides.</article-title>
            <source>Proc Nutr Soc</source>
            <year>1972</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>171</fpage>
            <page-range>171-7</page-range>
            <pub-id pub-id-type="pmid">4563292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orbak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ertekin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Selimoglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Konak</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hartnup disease masked by kwashiorkor.</article-title>
            <source>J Health Popul Nutr</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>413</fpage>
            <page-range>413-5</page-range>
            <pub-id pub-id-type="pmid">20824986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho&#x00142;ubiec</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leo&#x00144;czyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Staszewski</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>&#x00141;azarczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaworek</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Wojas-Pelc</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and clinical management of pellagra - a review.</article-title>
            <source>Folia Med Cracov</source>
            <year>2021</year>
            <month>Sep</month>
            <day>29</day>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-137</page-range>
            <pub-id pub-id-type="pmid">34882669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milovanovi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Djuki&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stepanovi&#x00107;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pekovi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vranjesevi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Hartnup disease (report of 2 cases in one family)].</article-title>
            <source>Srp Arh Celok Lek</source>
            <year>2000</year>
            <season>Mar-Apr</season>
            <volume>128</volume>
            <issue>3-4</issue>
            <fpage>97</fpage>
            <page-range>97-103</page-range>
            <pub-id pub-id-type="pmid">10932618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Prabhu</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Hartnup disease.</article-title>
            <source>Indian J Dermatol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-2</page-range>
            <pub-id pub-id-type="pmid">19967017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milne</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>The prognosis and management of renal tubular disorders.</article-title>
            <source>Proc R Soc Med</source>
            <year>1967</year>
            <month>Nov</month>
            <day>01</day>
            <volume>60</volume>
            <issue>11 Part 1</issue>
            <fpage>1149</fpage>
            <page-range>1149-52</page-range>
            <pub-id pub-id-type="pmid">6060714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidtke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Endres</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Roscher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ibel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Herschkowitz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pl&#x000f6;chl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hadorn</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinico-pathological case study.</article-title>
            <source>Eur J Pediatr</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>151</volume>
            <issue>12</issue>
            <fpage>899</fpage>
            <page-range>899-903</page-range>
            <pub-id pub-id-type="pmid">1473543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <article-title>[60th birthday of Prof. Prokop M&#x000e1;lek, M.D., D.S.c].</article-title>
            <source>Rozhl Chir</source>
            <year>1975</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>262</fpage>
            <page-range>262-4</page-range>
            <pub-id pub-id-type="pmid">1093261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galadari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sabarinathan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hartnup disease.</article-title>
            <source>Int J Dermatol</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>12</issue>
            <fpage>904</fpage>
            <pub-id pub-id-type="pmid">8125700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scriver</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Mahon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Clow</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Reade</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Kronick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lemieux</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Laberge</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.</article-title>
            <source>Am J Hum Genet</source>
            <year>1987</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>401</fpage>
            <page-range>401-12</page-range>
            <pub-id pub-id-type="pmid">3578280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22577.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shih</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Bixby</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Alpers</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Bartoscas</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Thier</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>Studies of intestinal transport defect in Hartnup disease.</article-title>
            <source>Gastroenterology</source>
            <year>1971</year>
            <month>Oct</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>445</fpage>
            <page-range>445-53</page-range>
            <pub-id pub-id-type="pmid">5157127</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
